291 related articles for article (PubMed ID: 11100272)
1. Pharmacokinetics and adverse events following 5-day repeated administration of lenograstim, a recombinant human granulocyte colony-stimulating factor, in healthy subjects.
Akizuki S; Mizorogi F; Inoue T; Sudo K; Ohnishi A
Bone Marrow Transplant; 2000 Nov; 26(9):939-46. PubMed ID: 11100272
[TBL] [Abstract][Full Text] [Related]
2. Pharmacodynamics and pharmacokinetics of single doses of subcutaneous pegylated human G-CSF mutant (Ro 25-8315) in healthy volunteers: comparison with single and multiple daily doses of filgrastim.
van Der Auwera P; Platzer E; Xu ZX; Schulz R; Feugeas O; Capdeville R; Edwards DJ
Am J Hematol; 2001 Apr; 66(4):245-51. PubMed ID: 11279634
[TBL] [Abstract][Full Text] [Related]
3. Treatment of normal individuals with granulocyte-colony-stimulating factor: donor experiences and the effects on peripheral blood CD34+ cell counts and on the collection of peripheral blood stem cells.
Stroncek DF; Clay ME; Petzoldt ML; Smith J; Jaszcz W; Oldham FB; McCullough J
Transfusion; 1996 Jul; 36(7):601-10. PubMed ID: 8701455
[TBL] [Abstract][Full Text] [Related]
4. Recombinant human interleukin-3 (rhIL-3) enhances the mobilization of peripheral blood progenitor cells by recombinant human granulocyte colony-stimulating factor (rhG-CSF) in normal volunteers.
Huhn RD; Yurkow EJ; Tushinski R; Clarke L; Sturgill MG; Hoffman R; Sheay W; Cody R; Philipp C; Resta D; George M
Exp Hematol; 1996 Jun; 24(7):839-47. PubMed ID: 8647235
[TBL] [Abstract][Full Text] [Related]
5. Reduced dose of lenograstim is as efficacious as standard dose of filgrastim for peripheral blood stem cell mobilization and transplantation: a randomized study in patients undergoing autologous peripheral stem cell transplantation.
Ataergin S; Arpaci F; Turan M; Solchaga L; Cetin T; Ozturk M; Ozet A; Komurcu S; Ozturk B
Am J Hematol; 2008 Aug; 83(8):644-8. PubMed ID: 18508321
[TBL] [Abstract][Full Text] [Related]
6. Flt3 ligand and thrombopoietin serum levels during peripheral blood stem cell mobilization with chemotherapy and recombinant human glycosylated granulocyte colony-stimulating factor (rhu-G-CSF, lenograstim) and after high-dose chemotherapy.
Bojko P; Pawloski D; Stellberg W; Schröder JK; Seeber S
Ann Hematol; 2002 Sep; 81(9):522-8. PubMed ID: 12373354
[TBL] [Abstract][Full Text] [Related]
7. Serum levels of endogenous and exogenous granulocyte colony-stimulating factor after autologous blood stem cell transplantation.
Shimazaki C; Uchiyama H; Fujita N; Araki S; Sudo Y; Yamagata N; Ashihara E; Goto H; Inaba T; Haruyama H
Exp Hematol; 1995 Dec; 23(14):1497-502. PubMed ID: 8542937
[TBL] [Abstract][Full Text] [Related]
8. Single-dose pegfilgrastim for the mobilization of allogeneic CD34+ peripheral blood progenitor cells in healthy family and unrelated donors.
Kroschinsky F; Hölig K; Poppe-Thiede K; Zimmer K; Ordemann R; Blechschmidt M; Oelschlaegel U; Bornhauser M; Rall G; Rutt C; Ehninger G
Haematologica; 2005 Dec; 90(12):1665-71. PubMed ID: 16330441
[TBL] [Abstract][Full Text] [Related]
9. Dose-dependent mobilisation of haematopoietic progenitor cells in healthy volunteers receiving glycosylated rHuG-CSF.
Höglund M; Smedmyr B; Simonsson B; Tötterman T; Bengtsson M
Bone Marrow Transplant; 1996 Jul; 18(1):19-27. PubMed ID: 8831991
[TBL] [Abstract][Full Text] [Related]
10. G-CSF serum pharmacokinetics during peripheral blood progenitor cell mobilization: neutrophil count-adjusted dosage might potentially improve mobilization and be more cost-effective.
Faulkner LB; Tucci F; Tamburini A; Tintori V; Lippi AA; Bambi F; Malentacca F; Azzari C; Gelli AM; Genovese F; Bernini G
Bone Marrow Transplant; 1998 Jun; 21(11):1091-5. PubMed ID: 9645570
[TBL] [Abstract][Full Text] [Related]
11. Phase I study of intravenously administered bacterially synthesized granulocyte-macrophage colony-stimulating factor and comparison with subcutaneous administration.
Lieschke GJ; Maher D; O'Connor M; Green M; Sheridan W; Rallings M; Bonnem E; Burgess AW; McGrath K; Fox RM
Cancer Res; 1990 Feb; 50(3):606-14. PubMed ID: 2404573
[TBL] [Abstract][Full Text] [Related]
12. Treatment of normal donors with rhG-CSF 16 micrograms/kg for mobilization of peripheral blood stem cells and their apheretic collection for allogeneic transplantation.
Majolino I; Buscemi F; Scimé R; Indovina A; Santoro A; Vasta S; Pampinella M; Catania P; Fiandaca T; Caronia F
Haematologica; 1995; 80(3):219-26. PubMed ID: 7545635
[TBL] [Abstract][Full Text] [Related]
13. Recombinant human granulocyte colony-stimulating factor can mobilize sufficient amounts of peripheral blood stem cells in healthy volunteers for allogeneic transplantation.
Matsunaga T; Sakamaki S; Kohgo Y; Ohi S; Hirayama Y; Niitsu Y
Bone Marrow Transplant; 1993 Feb; 11(2):103-8. PubMed ID: 7679596
[TBL] [Abstract][Full Text] [Related]
14. Lenograstim-mobilized peripheral blood progenitor cells in volunteer donors: an open label randomized split dose escalating study.
Basara N; Schmetzer B; Blau IW; Bischoff M; Günzelmann S; Kirsten D; Fauser AA
Bone Marrow Transplant; 2000 Feb; 25(4):371-6. PubMed ID: 10723579
[TBL] [Abstract][Full Text] [Related]
15. [Effect of recombinant human granulocyte colony stimulating factor (rhG-CSF) in patients receiving chemotherapy--phase I study].
Fukutani H; Ogawa M; Horikoshi N; Inoue K; Mukaiyama T; Nagamine D; Shinagawa K; Tabata M; Hirano A; Mizunuma N
Gan To Kagaku Ryoho; 1989 May; 16(5):2005-12. PubMed ID: 2471461
[TBL] [Abstract][Full Text] [Related]
16. Glycosylated and nonglycosylated recombinant human granulocyte colony-stimulating factor differently modifies actin polymerization in neutrophils.
Zucca A; Brizzi S; Riccioni R; Azzarà A; Ghimenti M; Carulli G
Clin Ter; 2006; 157(1):19-24. PubMed ID: 16669548
[TBL] [Abstract][Full Text] [Related]
17. Peripheral blood stem cell mobilization and apheresis: analysis of adverse events in 94 normal donors.
Murata M; Harada M; Kato S; Takahashi S; Ogawa H; Okamoto S; Tsuchiya S; Sakamaki H; Akiyama Y; Kodera Y
Bone Marrow Transplant; 1999 Nov; 24(10):1065-71. PubMed ID: 10578156
[TBL] [Abstract][Full Text] [Related]
18. Acute lung Injury in a healthy donor during mobilization of peripheral blood stem cells using granulocyte-colony stimulating factor alone.
Arimura K; Inoue H; Kukita T; Matsushita K; Akimot M; Kawamata N; Yamaguchi A; Kawada H; Ozak A; Arima N; Te C
Haematologica; 2005 Mar; 90(3):ECR10. PubMed ID: 15753051
[TBL] [Abstract][Full Text] [Related]
19. [Mobilization of autologous peripheral blood stem cells by cytosine arabinoside combined with recombinant human granulocyte colony-stimulating factor].
Shi Y; Han X; He X; Yang J; Liu P
Zhonghua Yi Xue Za Zhi; 2002 Apr; 82(7):462-6. PubMed ID: 12133516
[TBL] [Abstract][Full Text] [Related]
20. Blood stem cell procurement: donor safety issues.
Anderlini P; Przepiorka D; Körbling M; Champlin R
Bone Marrow Transplant; 1998 Jun; 21 Suppl 3():S35-9. PubMed ID: 9712491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
